Clinical trial · Observational
The Brain Metabolic Change in Chronic Cancer Pain Patient: FDG PET Image Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer pain deteriorated in quality of life and related with numerous psychosocial problems. Over the one third of cancer patient suffered from moderate to severe cancer pain, even under adequate pain management. The 18F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) images can provide quantitative results in clinical oncology. As a functional neuroimaging, the PET evidently provided anatomical activated regions, size, and spatial extent information. In this study, we use FDG-PET to investigate changes concerning the glucose metabolism in the brain with or without cancer pain. Therefore, we may provide useful information to treatment target in cancer pain patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Pain | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| FDG PET | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- with cancer pain
- description
- head and neck and esophageal cancer patients. with cancer pain
- interventionNames
- Diagnostic Test: FDG PET
- label
- without cancer pain
- description
- head and neck and esophageal cancer patients. without cancer pain=30
- interventionNames
- Diagnostic Test: FDG PET
Primary outcomes (1)
- measure
- Brain metabolism change
- timeFrame
- 12 months
- description
- The FDG-PET of Standardized uptake values (SUVs) were calculated for each voxel in the reconstructed images to investigate changes concerning the glucose metabolism in the brain with or without cancer pain
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: 1. Cancer patients who scheduled whole body FDG-PET image scan for clinically indicated. 2. Age \> 20 Exclusion Criteria: 1. Unable to complete questionnaires. 2. Prior evidence of brain metastases.
References
Publications (0)
Data not yet available